Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Gastrointestinal OncologyOpen Access

Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

DSD. S. ShenChinese Academy of SciencesRCRunzhe ChenSun Yat-sen UniversityQWQing WuYangtze River Pharmaceutical Group (China)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shen et al. (2024) studied this question.

synapsesocial.com/papers/68e66c6fb6db6435875f7bebhttps://doi.org/10.21037/jgo-24-295
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer2012 · 5,593 citations
  2. 2Classification of Surgical Complications2004 · 31,681 citations
  3. 3Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial2020 · 343 citations
  4. 4A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal Cancer2010 · 160 citations
  5. 5Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci2010 · 37 citations